Bank Of Montreal Axogen, Inc. Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$8.5 - $10.38 $83,317 - $101,744	9,802 Added 5.33%	193,680 $1.77 Million
Q1 2023 Jun 13, 2024	BUY	$7.53 - $10.95 $1.4 Million - $2.03 Million	185,550 New	185,550 $1.75 Million
Q4 2022 Feb 01, 2023	BUY	$9.44 - $13.09 $282,652 - $391,940	29,942 Added 19.45%	183,878 $1.84 Million
Q3 2022 Nov 10, 2022	SELL	$8.14 - $12.25 $1,522 - $2,290	-187 Reduced 0.12%	153,936 $1.9 Million
Q2 2022 Aug 11, 2022	BUY	$6.99 - $10.0 $1.08 Million - $1.54 Million	154,123 New	154,123 $1.48 Million
Q4 2021 Feb 11, 2022	SELL	$8.8 - $16.0 $2.5 Million - $4.54 Million	-283,586 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$15.23 - $21.72 $189,567 - $270,348	-12,447 Reduced 4.2%	283,586 $4.71 Million
Q2 2021 Aug 12, 2021	BUY	$17.8 - $23.5 $5.27 Million - $6.96 Million	296,033 New	296,033 $6.64 Million

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.